BlackRock »

Sutro Biopharma shares owned by BlackRock

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $24M 7.0M 3.46

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Sutro Biopharma

Suvretta Capital Management
BlackRock
BlackRock
Vanguard Group
MPM Oncology Impact Management
Point72 Asset Management
Samsara BioCapital
Citadel Advisors
Kynam Capital Management
Geode Capital Management
Parkman Healthcare Partners
Acadian Asset Management
State Street Corporation
Baillie Gifford & Co
Goldman Sachs Group

View all funds holding Sutro Biopharma